# Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma

> **NCT07240454** · NA · RECRUITING · sponsor: **Tao Liu** · enrollment: 143 (estimated)

## Conditions studied

- Chronic Subdural Hematoma

## Interventions

- **DRUG:** Aspirin Continuation
- **DRUG:** Aspirin Discontinuation

## Key facts

- **NCT ID:** NCT07240454
- **Lead sponsor:** Tao Liu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 143 (ESTIMATED)
- **Last updated:** 2025-11-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07240454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07240454, "Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07240454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*